Michael F. Roman - Dec 31, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Dec 31, 2023
Transactions value $
$35,222
Form type
4
Date filed
1/3/2024, 05:33 PM
Previous filing
Oct 3, 2023
Next filing
Feb 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $35.2K +320 +10.65% $110.07 3.32K Dec 31, 2023 Common Shares 320 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.